Changdu Medical was established in 2011. It started by providing products and services that meet client needs, and then developed into an integrated supplier for centers for reproductive medicine. At that time, reproductive medicine products were mainly imported, and the timeliness and stability of supply were affected by many factors. To solve relevant problems, localization was required to offer more options for centers for reproductive medicine.

In 2018, we expanded to the application of 3D printing in the medical field. As we all know, 3D printing is a cutting-edge technology today. Therefore, we followed the trend and established cooperation with the world's top 3D printing manufacturers to provide realizable 3D preoperative simulation models and 3D printing equipment services.

In 2016, the company entered the endocrine field, which showed our confidence in chronic diseases. The products were designed and manufactured in China and sold all over the world. We have established an online and offline mode with Xiyou Health and Ali Health to meet the "to B" and "to C" client needs.

In 2021, with the recurrence of COVID-19, WHO and the national health care system strengthened the construction of the critical care system. In response, we entered the field of transfusion management, to provide related products and services for the domestic and overseas medical system.